Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPIC | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
mRNA | PPP4R3A | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | HMGN2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | MDN1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | PLEC | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | ATP6V1G2-DDX39B | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | CDC40 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | FZD3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |